Deferred Tax Assets, Valuation Allowance of BeOne Medicines Ltd. from 31 Dec 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
BeOne Medicines Ltd. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2015 to 31 Dec 2025.
  • BeOne Medicines Ltd. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $3,648,017,000, a 7.2% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

BeOne Medicines Ltd. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $3,648,017,000 +$244,512,000 +7.2% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q4 2024 $3,403,505,000 +$632,035,000 +23% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q4 2023 $2,771,470,000 +$827,695,000 +43% 31 Dec 2023 10-K 26 Feb 2026 2025 FY
Q4 2022 $1,943,775,000 +$185,366,000 +11% 31 Dec 2022 10-K 26 Feb 2026 2025 FY
Q4 2021 $1,758,409,000 +$557,862,000 +46% 31 Dec 2021 10-K 27 Feb 2025 2024 FY
Q4 2020 $1,200,547,000 +$422,964,000 +54% 31 Dec 2020 10-K 26 Feb 2024 2023 FY
Q4 2019 $777,583,000 +$534,638,000 +220% 31 Dec 2019 10-K 28 Feb 2022 2021 FY
Q4 2018 $242,945,000 +$206,345,000 +564% 31 Dec 2018 10-K 25 Feb 2021 2020 FY
Q4 2017 $36,600,000 +$29,293,000 +401% 31 Dec 2017 10-K 02 Mar 2020 2019 FY
Q4 2016 $7,307,000 +$161,000 +2.3% 31 Dec 2016 10-K 28 Feb 2019 2018 FY
Q4 2015 $7,146,000 31 Dec 2015 10-K 28 Feb 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.